Abstract: Disclosed are an electronic system for performing control over a virtual reality space, an electronic device, and a method for operating same. The disclosed electronic system comprises: an electronic device which receives, as one or more touch gestures, control of a virtual reality space and/or an object within the virtual reality space and displays a first screen according to a corresponding first view frustum within the virtual reality space; and an HMD which is worn on the user's head and displays a second screen of the virtual reality space according to the head direction of the user at a time point corresponding to the second view frustum within the virtual reality space.

Abstract: A light irradiation apparatus includes first and second light sources that emit first light and second light, respectively. The first and the second lights have mutually different wavelengths at timings close to each other, regardless of overlap between the first light and the second light. The first light has a wavelength band for inducing destruction of bacteria by damaging a cell of the bacteria as the first light acts on a photosensitizer present in the bacteria. The second light has a wavelength band for inducing the destruction of the bacteria by changing the structure of a genetic material present in the cell of the bacteria. A dose of the second light source is less than 1/10 of a dose of the first light source.

Abstract: A display device includes a substrate comprising emission and non-emission areas. A light-emitting element overlaps the emission area and is on the substrate. A thin-film encapsulation layer overlaps with the emission and non-emission areas and is on the light-emitting element. A touch sensor layer is on the thin-film encapsulation layer. The touch sensor layer comprises a first conductive layer on the thin-film encapsulation layer. A touch insulating layer is on the first conductive layer. A second conductive layer is on the touch insulating layer. The touch insulating layer overlaps with the non-emission area and comprises a first surface facing the thin-film encapsulation layer. A second surface is opposite to the first surface and has a width in a first direction greater than that of the first surface. An inclined surface connects the first and second surfaces. The second conductive layer covers the second surface and the inclined surface.

Abstract: A light irradiation apparatus includes first and second light sources that emit first light and second light, respectively. The first and the second lights have mutually different wavelengths at timings close to each other, regardless of overlap between the first light and the second light. The first light has a wavelength band for inducing destruction of bacteria by damaging a cell of the bacteria as the first light acts on a photosensitizer present in the bacteria. The second light has a wavelength band for inducing the destruction of the bacteria by changing the structure of a genetic material present in the cell of the bacteria. A dose of the second light source is less than 1/10 of a dose of the first light source.

Abstract: The present invention relates to a fast disintegrating granular hair cleansing composition in which a wet granulation process, which is a pharmaceutical preparation method, is introduced into a method for preparing a cleanser. The fast disintegrating granular hair cleansing composition is prepared by a wet granulation process so as to be readily disintegrated into granules by using small force, because of a low hardness thereof, and can easily form creamy foam since a large surface area comes into contact with water. In addition, portability, convenience of use and sanitation can be improved when molding is carried out in a single-dose in which the entire amount is used at one time.

Abstract: Disclosed is a nozzle device and a minimally invasive injection device, and the nozzle device for a minimally invasive injection device according to an exemplary embodiment includes an outlet to generate a microjet of a liquid, and an injection part of a micro-scale size connected to the outlet and adapted to be inserted into a skin tissue to a preset depth.

Abstract: One aspect of the present invention relates to an effervescent tablet comprising a water-soluble lubricating agent, and a carbonated water cosmetic composition enabled to be used together therewith. One aspect of the present invention relates to an effervescent tablet comprising a crystalline #-hydroxy acid and a water-soluble lubricating agent, and a cosmetic composition using a skin toner for preventing the tablet from floating and allowing the tablet to rapidly form carbon dioxide gas in the cosmetic composition so as to maximize the visual effect and also the effect of carbon dioxide, thereby showing skin whitening, brightening and moisturizing effects and improving the pores.

Abstract: A flexible supercapacitor, a method of manufacturing the same, and a device including the same are provided, the flexible supercapacitor includes a first flexible electrode assembly, a second flexible electrode assembly corresponding to the first flexible electrode assembly, a separator for preventing contact between the first flexible electrode assembly and the second flexible electrode assembly, and an electrolyte between the first flexible electrode assembly and the second flexible electrode assembly. The flexible supercapacitor may include a tube including the first flexible electrode assembly, the second flexible electrode assembly, the separator, and the electrolyte.

Abstract: A medicinal fluid injection device for injecting a medicinal fluid into the skin of a patient so as to induce collagen generation and skin regeneration according to the radial diffusion of the medicinal fluid. The device includes a case part constituting the appearance; a medicinal fluid placing part mounted on the case part and in which a storage container storing a medicinal fluid is mounted; a medicinal fluid supply part connected to the storage container so as to supply a medicinal fluid; a medicinal fluid pressurization part mounted on the case part, and connected to the medicinal fluid supply part so as to pressurize the supplied medicinal fluid; and a medicinal fluid discharge part mounted on the medicinal fluid supply part so as to inject the medicinal fluid supplied from the medicinal fluid supply part.

Abstract: One aspect of the present invention relates to an effervescent tablet comprising a water-soluble lubricating agent, and a carbonated water cosmetic composition enabled to be used together therewith. One aspect of the present invention relates to an effervescent tablet comprising a crystalline #-hydroxy acid and a water-soluble lubricating agent, and a cosmetic composition using a skin toner for preventing the tablet from floating and allowing the tablet to rapidly form carbon dioxide gas in the cosmetic composition so as to maximize the visual effect and also the effect of carbon dioxide, thereby showing skin whitening, brightening and moisturizing effects and improving the pores.

Abstract: An apparatus for generating and storing electric energy, the apparatus including a fiber, an electric energy generation unit disposed on the fiber, and an electric energy storage unit disposed on the fiber.

Abstract: Disclosed is a nozzle device and a minimally invasive injection device, and the nozzle device for a minimally invasive injection device according to an exemplary embodiment includes an outlet to generate a microjet of a liquid, and an injection part of a micro-scale size connected to the outlet and adapted to be inserted into a skin tissue to a preset depth.

Abstract: Disclosed herein is a method of preparing a surface-modified inorganic filler, comprising the steps of: drying an inorganic filler; treating the inorganic filler with fluorine-containing gas to bond fluorine (F) to a part of the surface of the inorganic filler; and bonding a functional group-bonded silane coupling agent to another part of the surface of the inorganic filler, this other part of the surface thereof being not bonded with fluorine.

Abstract: This invention relates to a resin composition with good workability, including a liquid crystal oligomer, an epoxy resin, or a resin mixture thereof, and an inorganic filler having a nanocone shape, and to an insulating film for a printed circuit board, and a prepreg, which are manufactured using the resin composition.

Abstract: An apparatus for generating and storing electric energy, the apparatus including a fiber, an electric energy generation unit disposed on the fiber, and an electric energy storage unit disposed on the fiber.

Abstract: A flexible supercapacitor, a method of manufacturing the same, and a device including the same are provided, the flexible supercapacitor includes a first flexible electrode assembly, a second flexible electrode assembly corresponding to the first flexible electrode assembly, a separator for preventing contact between the first flexible electrode assembly and the second flexible electrode assembly, and an electrolyte between the first flexible electrode assembly and the second flexible electrode assembly. The flexible supercapacitor may include a tube including the first flexible electrode assembly, the second flexible electrode assembly, the separator, and the electrolyte.

Abstract: Disclosed is a controlled-release microparticle: including a matrix comprising a pharmacologically active component; and a controlled-release layer comprising a substance which forms a controlled-release stratum on the matrix. The disclosed controlled-release microparticle not only allows effective dual release control of a drug but can also exhibit outstanding dissolution characteristics even when a small amount of coating substance is used.

Abstract: Disclosed are a method for preparing a powder containing a nanoparticulated sparingly soluble drug, a powder prepared thereby, and a pharmaceutical composition containing the same. The disclosed method includes: providing a uniformly dispersed solution of a sparingly soluble drug which is formed into nanoparticles in the presence of a surface stabilizer; mixing the uniformly dispersed solution with a water-soluble dispersant solution; and drying the mixed solution to obtain the powder. When the powder containing the nanoparticulated sparingly soluble drug obtained by the disclosed method is redispersed in an aqueous solution, the sparingly soluble drug retains a particle size in the nano scale while the solubility and the dissolution rate of the drug are increased, thereby providing enhanced bioavailability. Consequently, the present disclosure can be useful in the development of preparations of a sparingly soluble drug for oral or parenteral administration.